New SAA Serum Amyloid A Protein Rapid Test Kit Launches to Boost Point-of-Care Inflammatory Diagnosis

A new SAA Serum Amyloid A Protein Rapid Test Kit has been officially released, delivering fast, accurate, and convenient in vitro quantitative detection for clinical and point-of-care settings. Designed for whole blood, serum, and plasma specimens, the kit uses advanced immunochromatographic technology to support early screening, differential diagnosis, and dynamic monitoring of acute and chronic inflammatory conditions.
Serum Amyloid A (SAA) is a critical acute-phase inflammatory protein that rises sharply within 3–6 hours of infection or tissue injury, making it far more sensitive than traditional markers in identifying viral infections and early-stage inflammation. Unlike C-reactive protein (CRP), which mainly elevates in bacterial infections, SAA increases significantly in both bacterial and viral infections, enabling more comprehensive infection assessment. When combined with CRP, the test greatly improves diagnostic accuracy for fever, respiratory infections, and pediatric inflammatory conditions.
The test offers a complete workflow solution with results in 10–15 minutes, no complex equipment or centrifugation required, and simple one-step operation suitable for clinics, emergency departments, community health centers, and field testing. It features a wide detection range, high specificity based on monoclonal antibodies, and strong stability supporting storage at 2°C–30°C. Clinical validation shows high precision and consistency, minimizing false results and supporting reliable clinical decision-making.
This SAA rapid test kit addresses unmet needs for fast, on-site inflammatory testing, especially in settings with limited laboratory resources. By providing timely quantitative data, it helps clinicians initiate early intervention, optimize antimicrobial use, monitor treatment response, and improve patient outcomes. Its launch strengthens the toolkit for rapid infectious disease management and chronic inflammatory disease monitoring.
With growing demand for efficient point-of-care diagnostics, the SAA Serum Amyloid A Protein Rapid Test Kit brings reliable, user-friendly, and cost-effective testing to global healthcare providers. It supports better patient triage, reduces diagnostic delays, and advances personalized care for inflammatory and infectious diseases.
We Baysen medical can supply SAA rapid Test Kit for early diagnosis. Welcome to contact us for more details.


Post time: May-19-2026